Oncology
From the Journals
ICI combinations show survival benefit in advanced renal cancer
Authors of a systematic review suggest ICI combinations should be available worldwide as first-line treatment for advanced renal cancer.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
From the Journals
Atezolizumab fails to improve outcomes in postsurgery kidney cancer
Study authors call for greater attention to patient selection for RCC adjuvant immunotherapy.
From the Journals
Chronic hepatitis B infections associated with a range of liver malignancies
Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
Latest News
Link between PCOS and increased risk of pancreatic cancer?
“These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”
Latest News
A cost-effective de-escalation strategy in advanced melanoma
While the use of immunotherapies over the past decade has improved the prognosis for patients with advanced melanoma, these drugs come with a...
From the Journals
Patients at risk for Barrett’s esophagus rarely screened
Adults with GERD and their primary care providers may lack knowledge about recommended screening for Barrett’s esophagus, a new survey shows.
Guidelines
USPSTF holds firm on postmenopausal hormone recommendations
The central message of updated recommendations from the U.S. Preventive Services Task Force’s on using hormone therapy to prevent chronic...
From the Journals
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults...